Visual auras, similar to those seen during a migraine, were linked to the presence of small brain embolisms observable 1 day ...

For patients with atrial fibrillation, catheter ablation reduces the risk of ischemic stroke at more than 30 days, mortality, ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

Ten-year survival was favorable among patients with follicular thyroid carcinoma wo underwent successful postoperative ablation.

Heart ablation procedures can take four hours or more. During the procedure, the cardiologist may ask you questions regarding ...

Thyroid ablation is suitable for patients with thyroid nodules or hyperthyroidism who have not responded to traditional ...

The global dysmenorrhea treatment market, valued at approximately USD 5,937.8 million in 2022, is projected to reach USD 6,324.5 million in 2023 and USD 13,106.5 million by 2032, exhibiting a CAGR of ...

In endometrial cancer, upwards of 70% of tumours are mismatch repair proficient (MMRp)/microsatellite stable (MSS), so the new approval unlocks the lion's share of the market for GSK.

GSK's drug was cleared by the FDA for use in relapsed endometrial cancer with dMMR mutations in 2021, while Keytruda got the go-ahead for relapsed cases with MSI-H or dMMR mutations last year.